ACS Biomaterials Science & Engineering · 2022 · 19 citations · 77 references
MedicineBioengineeringBiomedical EngineeringBiomaterialsBone MetabolismTissue EngineeringBioceramicsBone Graft SubstitutesBone SubstitutesBone TissueOsteogenesisSynthetic Bone SubstitutesCalcium-deficient HydroxyapatiteHydroxyapatiteHydroxyapatite BiomaterialsHydroxyapatite-based Bone SubstitutesHydroxyapatite-based MaterialsOsteogenic DifferentiationOsteogenic MarkersSurface Area
) than cHA. In addition, BcHA treatment led to increased expression of regenerative genes such as VEGF-A, RANKL, and BMP-2. In vitro results demonstrated that BcHA has tremendous osteogenic, angiogenic, and immunomodulatory potential to be employed as a "versatile-in-all-trades" modality in various bone tissue engineering applications.
77
Kara L. Spiller, Sina Nassiri, Claire E. Witherel et al. · Biomaterials · 2014 · 773 citations · Full text
VEGF may contribute to macrophage recruitment and M2 polarization in the decidua
Karen Wheeler, Manoj Kumar Jena, Bhola Shankar Pradhan et al. · PLoS ONE · 2018 · 265 citations · Full text